Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Attix Pharmaceuticals is recalling Baclofen active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Fluorescein Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Mitotane active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Gatifloxacin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Tolfenamic Acid active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Paroxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling crospovidone pharmaceutical ingredient distributed nationwide to compounding pharmacies and research organizations due to potential penicillin cross-contamination.
Attix Pharmaceuticals is recalling Secretin Acetate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Diphemanil Methylsulfate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Domperidone active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Trehalose Dihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Mebendazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Ethopropazine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Furazolidine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Dexmedetomidine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from repackaging in a shared facility.
Attix Pharmaceuticals is recalling Sildenafil Citrate active pharmaceutical ingredient due to potential penicillin cross contamination during repackaging.
Attix Pharmaceuticals is recalling Levothyroxine Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Bromfenac Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Mycophenolate Mofetil active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling 2-Deoxy-D-Glucose active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Pergolide Mesylate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Attix Pharmaceuticals is recalling Lincomycin HCl Monohydrate active pharmaceutical ingredient due to potential penicillin cross contamination during repackaging.
Attix Pharmaceuticals is recalling Flutamide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Hyoscyamine Sulfate Dihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Attix Pharmaceuticals is recalling Methotrexate Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.